A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease
Public ClinicalTrials.gov record NCT00675623. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Global Phase 3, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Oral Dimebon in Patients With Mild-to-Moderate Alzheimer's Disease (CONNECTION)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Connection Study is a six-month confirmatory Phase 3 study to determine the safety and efficacy of Dimebon in the treatment of mild-to-moderate Alzheimer's disease (AD).
Study identification
- NCT ID
- NCT00675623
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 598 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2008 (Type not available)
- Primary completion
- Dec 2009 (Actual)
- Completion
- Not listed
- Last update posted
- Sep 27, 2016
Started 2008
United States locations
- U.S. sites
- 28
- U.S. states
- 15
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85004 | — |
| Not listed | Costa Mesa | California | — | — |
| Not listed | Fresno | California | 93720 | — |
| Not listed | Rancho Mirage | California | — | — |
| Not listed | Hamden | Connecticut | — | — |
| Not listed | New Haven | Connecticut | — | — |
| Not listed | Norwalk | Connecticut | — | — |
| Not listed | Hallandale | Florida | 33009 | — |
| Not listed | Hialeah | Florida | — | — |
| Not listed | Miami | Florida | 33137 | — |
| Not listed | North Miami | Florida | 33161 | — |
| Not listed | Sunrise | Florida | 33351 | — |
| Not listed | West Palm Beach | Florida | 33407 | — |
| Not listed | Indianapolis | Indiana | 46260 | — |
| Not listed | Paducah | Kentucky | 42003 | — |
| Not listed | Newton | Massachusetts | 02459 | — |
| Not listed | Ann Arbor | Michigan | — | — |
| Not listed | St Louis | Missouri | 63044 | — |
| Not listed | Brooklyn | New York | — | — |
| Not listed | Cedarhurst | New York | 11516 | — |
| Not listed | New York | New York | — | — |
| Not listed | Rochester | New York | 14620 | — |
| Not listed | Staten Island | New York | — | — |
| Not listed | Morganton | North Carolina | 28655 | — |
| Not listed | Centerville | Ohio | — | — |
| Not listed | Norristown | Pennsylvania | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | Middleton | Wisconsin | 53562 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00675623, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 27, 2016 · Synced Nov 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00675623 live on ClinicalTrials.gov.